SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Stay informed with null’s coverage and analysis for Fortune.
Page 72 of 100
Newsletters
The top two underrated CEOs
By
David Meyer
and
Alan Murray
Health
With supplies running low, Europe approves AstraZeneca’s COVID-19 vaccine for all adults
By
Jeremy Kahn
and
David Meyer
Retail
Dr. Martens IPO kicks off to huge investor demand
By
David Meyer
Newsletters
CEOs discuss working with government in 2021
By
David Meyer
and
Alan Murray
Health
Germany may not use AstraZeneca’s vaccine for over-65s, as experts debate lack of data
By
Jeremy Kahn
and
David Meyer
Health
France’s Valneva starts making COVID-19 vaccine in Scotland, ahead of trial results and approval
By
David Meyer
Newsletters
CEOs want Biden to restore trust in government
By
David Meyer
and
Alan Murray
Newsletters
Many companies still have no net-zero climate plan
By
David Meyer
and
Alan Murray
Health
Furious at AstraZeneca, the EU plans export controls for COVID vaccines made on its home turf
By
David Meyer
Newsletters
Elon Musk loves Joe Biden
By
David Meyer
and
Alan Murray
Tech
Grindr fined millions for sharing users’ sexual orientation and location with advertisers
By
David Meyer
Health
AstraZeneca is finding it hard to keep its COVID-19 vaccine promises
By
David Meyer
Newsletters
We are all tech companies now
By
David Meyer
and
Alan Murray
Health
Good news: COVID-19 vaccine skepticism is waning. Bad news: That might not be enough
By
Bernhard Warner
and
David Meyer
Newsletters
Friday feedback: Tax and PACs
By
David Meyer
and
Alan Murray